Abstract
The global markets for atrial fibrillation (AF) treatment devices are growing
rapidly as physicians increasingly focus on AF and the usefulness of medical
devices in its treatment. Procedure volumes and device sales will increase as
the incidence and prevalence of AF rises in the US, Europe, and Japan. The
market for AF treatment devices will further expand as clinical data and
product innovations continue to promote their use. Price erosion and ongoing
competition with AF' s primary treatment option, drug therapy, will continue to
limit the rate of market growth through 2013.
| 
View Cart
